Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Understanding histone deacetylation in Huntington's disease.

Valor LM.

Oncotarget. 2016 Dec 12. doi: 10.18632/oncotarget.13924. [Epub ahead of print] No abstract available.

2.

New recommendations for pneumococcal vaccination in patients with autoimmune and inflammatory diseases.

Hernández-Flórez D, González-Benítez R, Valor L.

Med Clin (Barc). 2016 Dec 5. pii: S0025-7753(16)30516-4. doi: 10.1016/j.medcli.2016.10.007. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
27931862
3.

Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity.

Hernández-Flórez D, Valor L.

Reumatol Clin. 2016 Nov - Dec;12(6):303-306. doi: 10.1016/j.reuma.2016.07.011. English, Spanish. No abstract available.

4.

The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?

Morales-Lozano R, Martínez-Barrio J, González-Fernández ML, López-Longo FJ, Ovalles-Bonilla JG, Valor L, Janta I, Nieto JC, Hernández-Flórez D, González CM, Monteagudo I, Garrido J, Carreño L, Naredo E.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):609-17.

5.

Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?

Valor L, Martínez-Estupiñán L, Janta I, Nieto JC, Ovalles-Bonilla JG, González-Fernández C, Del Rio T, Hernández-Flórez D, Monteagudo I, López-Longo FJ, Naredo E.

Rheumatol Int. 2016 Jun;36(6):793-7. doi: 10.1007/s00296-016-3477-4.

PMID:
27072348
6.

To what extent is foot pain related to biomechanical changes and ultrasound-detected abnormalities in rheumatoid arthritis?

González-Fernández ML, Valor L, Morales-Lozano R, Hernández-Flórez D, López-Longo FJ, Martínez D, González CM, Monteagudo I, Martínez-Barrio J, Garrido J, Naredo E.

Clin Exp Rheumatol. 2016 May-Jun;34(3):480-8.

PMID:
27050868
7.

Treatment with monoclonal antibodies and pregnancy in women with systemic inflammatory diseases: A special situation.

Valor L, Ovalles-Bonilla JG, Hernández-Flórez D, López-Longo FJ.

Reumatol Clin. 2016 Nov - Dec;12(6):359-360. doi: 10.1016/j.reuma.2016.01.006. English, Spanish. No abstract available.

8.

Structural damage in rheumatoid arthritis: comparison between tendon damage evaluated by ultrasound and radiographic damage.

Janta I, Stanciu D, Hinojosa M, Nieto-González JC, Valor L, Bello N, Serrano B, Mata-Martínez C, Martínez-Barrio J, Ovalles-Bonilla JG, González CM, López-Longo FJ, Monteagudo I, Naredo E, Carreño L.

Rheumatology (Oxford). 2016 Jun;55(6):1042-6. doi: 10.1093/rheumatology/kew020.

9.

Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury.

Pardo L, Schlüter A, Valor LM, Barco A, Giralt M, Golbano A, Hidalgo J, Jia P, Zhao Z, Jové M, Portero-Otin M, Ruiz M, Giménez-Llort L, Masgrau R, Pujol A, Galea E.

Glia. 2016 May;64(5):853-74. doi: 10.1002/glia.22969.

PMID:
26880229
10.

Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.

Guiretti D, Sempere A, Lopez-Atalaya JP, Ferrer-Montiel A, Barco A, Valor LM.

Neurobiol Dis. 2016 May;89:190-201. doi: 10.1016/j.nbd.2016.02.004.

PMID:
26851501
11.

Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

Janta I, Valor L, De la Torre I, Martínez-Estupiñán L, Nieto JC, Ovalles-Bonilla JG, Martínez-Barrio J, Bello N, Hinojosa M, Montoro M, González CM, López-Longo J, Monteagudo I, Carreño L, Naredo E.

Rheumatol Int. 2016 Mar;36(3):387-96. doi: 10.1007/s00296-015-3409-8.

PMID:
26712373
12.

Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population.

Martínez-Barrio J, Ovalles-Bonilla JG, López-Longo FJ, González CM, Montoro M, Valor L, Martínez LP, Nieto JC, Hinojosa-Dávila MC, Bello N, Monteagudo I, Naredo E, Carreño L.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):788-94.

PMID:
26575830
13.

Agreement in assessment of infliximab and adalimumab levels in rheumatoid arthritis: interlaboratory and interassay comparison.

Valor L, Hernández-Flórez D, de la Torre I, Llinares F, Rosas J, Yagüe J, Garrido J, Naredo E.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):617-23.

PMID:
26316061
14.

Investigating the link between disease activity and infliximab serum levels in rheumatoid arthritis patients.

Valor L, Hernández-Flórez D, de la Torre I, Del Río T, Nieto JC, González C, López-Longo FJ, Monteagudo I, Llinares F, Rosas J, Garrido J, Naredo E, Carreño L.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):805-11.

PMID:
26314759
15.

Protein-kinase inhibitors: A new treatment pathway for autoimmune and inflammatory diseases?

Hernández-Flórez D, Valor L.

Reumatol Clin. 2016 Mar-Apr;12(2):91-9. doi: 10.1016/j.reuma.2015.06.004. English, Spanish.

16.

Impact of the thickness of the subcutaneous tissue at the site of injection as measured by ultrasound on the therapeutic response to subcutaneous anti-tumor necrosis factor drugs.

Del Río T, Valor L, de la Torre I, Naredo E.

Reumatol Clin. 2016 Sep-Oct;12(5):300-1. doi: 10.1016/j.reuma.2015.06.005. English, Spanish. No abstract available.

17.

Epigenetic-based therapies in the preclinical and clinical treatment of Huntington's disease.

Valor LM.

Int J Biochem Cell Biol. 2015 Oct;67:45-8. doi: 10.1016/j.biocel.2015.04.009. Review.

PMID:
25936670
18.

Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.

Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete JD, Raya E, Magro-Checa C, Vasilopoulos Y, Sarafidou T, Caliz R, Ferrer MA, Joven B, Carreira P, Balsa A, Pascual-Salcedo D, Blanco FJ, Moreno-Ramos MJ, Fernández-Nebro A, Ordóñez MC, Alegre-Sancho JJ, Narváez J, Navarro-Sarabia F, Moreira V, Valor L, García-Portales R, Marquez A, Martin J, Gómez-Reino JJ, Gonzalez A.

Pharmacogenomics J. 2016 Apr;16(2):137-40. doi: 10.1038/tpj.2015.29.

PMID:
25896535
19.

Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.

Montes A, Perez-Pampin E, Navarro-Sarabia F, Moreira V, de la Serna AR, Magallares B, Vasilopoulos Y, Sarafidou T, Fernández-Nebro A, Ordóñez Mdel C, Narváez J, Cañete JD, Marquez A, Pascual-Salcedo D, Joven B, Carreira P, Moreno-Ramos MJ, Caliz R, Ferrer MA, Garcia-Portales R, Blanco FJ, Magro C, Raya E, Valor L, Alegre-Sancho JJ, Balsa A, Martin J, Plant D, Isaacs J, Morgan AW, Barton A, Wilson AG; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS)., Gómez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2015 Mar 18;17:63. doi: 10.1186/s13075-015-0571-z.

20.

Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence.

Carvajal F, Alcaraz-Iborra M, Lerma-Cabrera JM, Valor LM, de la Fuente L, Sanchez-Amate Mdel C, Cubero I.

Behav Brain Res. 2015;287:230-7. doi: 10.1016/j.bbr.2015.03.046.

PMID:
25827928
Items per page

Supplemental Content

Support Center